Please use this identifier to cite or link to this item: https://repositorio.usj.es/handle/123456789/517

Title: A Novel Pan-Negative-Gating Modulator of K(Ca)2/3 Channels, Fluoro-Di-Benzoate, RA-2, Inhibits Endothelium-Derived Hyperpolarization-Type Relaxation in Coronary Artery and Produces Bradycardia In Vivo
Authors: Olivan-Viguera, Aida ORCID RESEARCHERID
Valero Gracia, Marta Sofía ORCID SCOPUSID
Coleman, Nichole SCOPUSID
Brown, Brandon M. ORCID SCOPUSID
Laria Campaña, Celia
Murillo, Mª Divina ORCID RESEARCHERID SCOPUSID
Gálvez, José Antonio ORCID SCOPUSID
Díaz-de-Villegas, María Dolores ORCID RESEARCHERID
Wulff, Heike ORCID SCOPUSID
Badorrey, Ramón RESEARCHERID SCOPUSID
Köhler, Ralf ORCID SCOPUSID
Keywords: CA2+-ACTIVATED K+ CHANNEL; ACTIVATED POTASSIUM CHANNELS; SMALL-CONDUCTANCE; K(CA)3.1; ATRIAL; SKA-31; SK3; EXPRESSION; PHARMACOLOGY; CONTRIBUTES
Issue Date: Feb-2015
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
Citation: Oliván-Viguera, A., Valero, M.S., Coleman, N., Brown, B.M., Laría, C., Divina Murillo, M., Gálvez, J.A., Díaz-De-Villegas, M.D., Wulff, H., Badorrey, R., Köhler, R., 2015. A Novel Pan-Negative-Gating Modulator of KCa2/3 Channels, Fluoro-Di-Benzoate, RA-2, Inhibits Endothelium-Derived Hyperpolarization–Type Relaxation in Coronary Artery and Produces Bradycardia In Vivo. Molecular Pharmacology 87, 338–348.. doi:10.1124/mol.114.095745
Abstract: Small/intermediate conductance K-Ca channels (K(Ca)2/3) are Ca2+/calmodulin regulated K+ channels that produce membrane hyperpolarization and shape neurologic, epithelial, cardiovascular, and immunologic functions. Moreover, they emerged as therapeutic targets to treat cardiovascular disease, chronic inflammation, and some cancers. Here, we aimed to generate a new pharmacophore for negative-gating modulation of K(Ca)2/3 channels. We synthesized a series of mono-and dibenzoates and identified three dibenzoates [1,3-phenylenebis(methylene) bis(3-fluoro-4-hydroxybenzoate) (RA-2), 1,2-phenylenebis(methylene) bis(3-fluoro-4-hydroxybenzoate), and 1,4-phenylenebis(methylene) bis(3-fluoro-4-hydroxybenzoate)] with inhibitory efficacy as determined by patch clamp. Among them, RA-2 was the most drug-like and inhibited human K(Ca)3.1 with an IC50 of 17 nM and all three human K(Ca)2 subtypes with similar potencies. RA-2 at 100 nM right-shifted the K(Ca)3.1 concentration-response curve for Ca2+ activation. The positive-gating modulator naphtho[1,2-d]thiazol-2-ylamine (SKA-31) reversed channel inhibition at nanomolar RA-2 concentrations. RA-2 had no considerable blocking effects on distantly related large-conductance K(Ca)1.1, Kv1.2/1.3, Kv7.4, hERG, or inwardly rectifying K+ channels. In isometric myography on porcine coronary arteries, RA-2 inhibited bradykinin-induced endothelium-derived hyperpolarization (EDH)-type relaxation in U46619-precontracted rings. Blood pressure telemetry in mice showed that intraperitoneal application of RA-2 (<= 100 mg/kg) did not increase blood pressure or cause gross behavioral deficits. However, RA-2 decreased heart rate by approximate to 145 beats per minute, which was not seen in K(Ca)3.1(-/-) mice. In conclusion, we identified the K(Ca)2/3-negative-gating modulator, RA-2, as a new pharmacophore with nanomolar potency. RA-2 may be of use to generate structurally new types of negative-gating modulators that could help to define the physiologic and pathomechanistic roles of K(Ca)2/3 in the vasculature, central nervous system, and during inflammation in vivo.
URI: https://repositorio.usj.es/handle/123456789/517
ISSN: 1521-0111
Appears in Collections:Artículos de revistas

Files in This Item:
File Description SizeFormat 
A Novel Pan-Negative-Gating Modulator of KCa23 Channels.pdf1,61 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons